Cellectis (CLLS) Assets Average (2015 - 2026)

Cellectis (CLLS) recorded quarterly Assets Average of $307.0 million in Q1 2026, down 8.07% quarter-over-quarter from $333.9 million in Q4 2025, and down 17.89% on a YoY basis from $373.8 million in Q1 2025.

Cellectis (CLLS) Assets Average (2015 - 2026) Analysis & Trends

Cellectis' Assets Average history runs 12 years deep, the most recent figure standing at $307.0 million for Q1 2026.

  • In Q1 2026, Assets Average fell 17.89% year-over-year to $307.0 million; the TTM figure through Mar 2026 stood at $307.0 million (down 17.89% YoY), while the FY2025 annual figure was $354.1 million, down 1.33% from the prior year.
  • Assets Average was $307.0 million for Q1 2026 at Cellectis, down from $333.9 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $401.5 million in Q3 2024 to a low of $218.7 million in Q3 2023.
  • Historically, Assets Average has averaged $323.2 million across 5 years, with a median of $334.0 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Assets Average slumped 31.97% in 2022, then surged 83.6% in 2024.
  • A 5-year view of Assets Average shows it stood at $270.4 million in 2022, then advanced by 0.59% to $272.0 million in 2023, then surged by 43.28% to $389.7 million in 2024, then decreased by 14.33% to $333.9 million in 2025, then retreated by 8.07% to $307.0 million in 2026.
  • The last three Assets Average figures came in at $307.0 million (Q1 2026), $333.9 million (Q4 2025), and $348.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 33.42 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.91 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13.04 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.72 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 26.03 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 40.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.06 Bn
9 Abivax 91.96 Bn 91.96 Bn - 660.38 Mn
10 Cellectis 17.40 Bn 17.21 Bn - 306.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 306.95 Mn
Dec 31, 2025 333.88 Mn
Sep 30, 2025 348.51 Mn
Jun 30, 2025 359.03 Mn
Mar 31, 2025 373.82 Mn
Dec 31, 2024 389.71 Mn
Sep 30, 2024 401.51 Mn
Jun 30, 2024 380.80 Mn
Mar 31, 2024 344.36 Mn
Dec 31, 2023 271.99 Mn
Sep 30, 2023 218.69 Mn
Jun 30, 2023 239.54 Mn
Mar 31, 2023 256.31 Mn
Dec 31, 2022 270.40 Mn
Sep 30, 2022 300.23 Mn
Jun 30, 2022 334.04 Mn
Mar 31, 2022 364.63 Mn
Dec 31, 2021 397.48 Mn
Sep 30, 2021 435.23 Mn
Jun 30, 2021 450.14 Mn